Article
Human immunodeficiency virus type 1 pharmacogenomics in clinical practice: relevance of HIV-1 drug resistance testing (Part 2).
Journal of environmental pathology, toxicology and oncology : official organ of the International Society for Environmental Toxicology and Cancer - 1 Jan 2003
Patarca Roberto, Isava Alejandro, Campo Rafael, Rodriguez Nelson J, Nunez Enriqueta, Alter Michael, Marchette Margaret, Sanabia Mirtha M, Mitchell Charles, Rivera Delia, Scott Gwendolyn, Jayaweera Dushyantha, Moreno Jose, Boulanger Catherine, Kolber Michael, Mask Cindy W, Sierra Eduardo Meneses, Vallejo Ricardo, Page J Brian, Klimas Nancy G, Fletcher MaryAnn
Abstract excerpt
Throughout most of the past century, physicians could offer patients no treatments for infections caused by viruses. The experience with treatment of infection by human immunodeficiency virus (HIV) has changed the way healthcare workers deal with viral infections and has triggered a growing rate of discovery and use of antiviral agents, the first fruits of the expanding genomics revolution. HIV treatment also...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.